Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma
Rina Nakajima, Tomomitsu Miyagaki, Hiroaki Kamijo, et al.
Journal of Dermatological Science (2019) Vol. 96, Iss. 3, pp. 134-142
Open Access | Times Cited: 18

Showing 18 citing articles:

A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
Yan Lv, Xiao Ma, Yuxin Ma, et al.
Genes & Diseases (2022) Vol. 10, Iss. 6, pp. 2366-2382
Open Access | Times Cited: 67
Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma
Veronica Stolearenco, Martin R. J. Namini, Siri S. Hasselager, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 39
The regulation of immune checkpoints by the hypoxic tumor microenvironment
Min Hu, Yongfu Li, Yuting Lu, et al.
PeerJ (2021) Vol. 9, pp. e11306-e11306
Open Access | Times Cited: 33
Multifaceted roles of Galectins: from carbohydrate binding to targeted cancer therapy
Nan Zhang, Qiao Liu, Dan Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Galectin-9 – ligand axis: an emerging therapeutic target for multiple myeloma
Rajib Shil, Norhan B. B. Mohammed, Charles J. Dimitroff
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
Alimu Xierenguli, Juan Zhang, Nannan Pang, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 6
The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome
Denis Miyashiro, Bruno de Castro e Souza, Marina Passos Torrealba, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 936-936
Open Access | Times Cited: 10
Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
Yuanwei Shi, Danting Tang, Xiaoqi Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Modulation of the Gal-9/TIM-3 Immune Checkpoint with α-Lactose. Does Anomery of Lactose Matter?
Christian Bailly, Xavier Thuru, Bruno Quesnel
Cancers (2021) Vol. 13, Iss. 24, pp. 6365-6365
Open Access | Times Cited: 11
Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis
Haotian Liu, Qiuying Dai, Yixian Li, et al.
Hematology (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 4
Targeting galectins in T cell-based immunotherapy within tumor microenvironment
Qiuyang Jin, Yingshuang Li, Xing-Hui Qiao, et al.
Life Sciences (2021) Vol. 277, pp. 119426-119426
Closed Access | Times Cited: 9
The Transcription Factor Twist1 Has a Significant Role in Mycosis Fungoides (MF) Cell Biology: An RNA Sequencing Study of 40 MF Cases
Marjaana Häyrinen, Jenni Kiiskilä, Annamari Ranki, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1527-1527
Open Access | Times Cited: 3
CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia
Heba A. Ahmed, Asmaa Nafady, Eman Ahmed, et al.
Annals of Hematology (2023) Vol. 103, Iss. 3, pp. 781-792
Open Access | Times Cited: 3
Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages
Tania Reyes‐Vallejo, Ileana Conde‐Rodríguez, Jocelyn Serna-Villalobos, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 1211-1220
Open Access | Times Cited: 5
“Next top” mouse models advancing CTCL research
Yixin Luo, Frank R. de Gruijl, Maarten H. Vermeer, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Prognostic Potential of Galectin-9 mRNA Expression in Chronic Lymphocytic Leukemia
Agnieszka Bojarska‐Junak, Wioleta Kowalska, Sylwia Chocholska, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5370-5370
Open Access | Times Cited: 1
Immune Checkpoint Molecules and Co-stimulatory Molecules in Cutaneous T-cell Lymphoma
Tomomitsu Miyagaki
The Nishinihon Journal of Dermatology (2022) Vol. 84, Iss. 3, pp. 187-193
Closed Access
Efeito de nanovesículas extracelulares derivadas de linhagens tumorais de linfoma T cutâneo em queratinócitos imortalizados
Marina Passos Torrealba
(2022)
Open Access
Page 1

Scroll to top